| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors
|
Eng, Cathy
|
|
|
20 |
3 |
p. 519-530
|
artikel
|
| 2 |
CIBMTR Registry Data on Inotuzumab Ozogamicin Treatment in Patients with ALL Who Proceeded to Hematopoietic Stem Cell Transplant—A Podcast
|
de Lima, Marcos
|
|
|
20 |
3 |
p. 371-374
|
artikel
|
| 3 |
Efficacy and Toxicity of Pemigatinib in Advanced Cholangiocarcinoma Harboring FGFR Fusions or Rearrangements: A Systematic Review and Meta-analysis
|
Akkus, Erman
|
|
|
20 |
3 |
p. 389-403
|
artikel
|
| 4 |
Efficacy of First-Line Treatments for Advanced Renal Cell Carcinoma: A Bayesian Network Meta-analysis of Objective Response, Progression-Free Survival, and Overall Survival
|
Schmidinger, Manuela
|
|
|
20 |
3 |
p. 375-387
|
artikel
|
| 5 |
Immunotherapy for Renal Cell Carcinoma—What More is to Come?
|
Yochum, Zachary A.
|
|
|
20 |
3 |
p. 467-483
|
artikel
|
| 6 |
Impact of EGFR Mutation Subtypes on Response to Chemoimmunotherapy and Chemotherapy in Non-Small-Cell Lung Cancer After EGFR-TKI Failure
|
Morimoto, Kenji
|
|
|
20 |
3 |
p. 531-541
|
artikel
|
| 7 |
Navigating the Landscape of Resistance Mechanisms in Antibody–Drug Conjugates for Cancer Treatment
|
Lalli, Gloria
|
|
|
20 |
3 |
p. 419-430
|
artikel
|
| 8 |
Olaparib Monotherapy or in Combination with Abiraterone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a BRCA Mutation
|
Saad, Fred
|
|
|
20 |
3 |
p. 445-466
|
artikel
|
| 9 |
Potential Mechanisms for Immunotherapy Resistance in Adult Soft-Tissue Sarcoma
|
Kret, Zaina S.
|
|
|
20 |
3 |
p. 485-502
|
artikel
|
| 10 |
PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
|
Hamilton, Erika P.
|
|
|
20 |
3 |
p. 431-444
|
artikel
|
| 11 |
Safety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical Trial
|
De La Cerda, Jose
|
|
|
20 |
3 |
p. 503-517
|
artikel
|
| 12 |
The Impact of Uncommon HRR Alterations as Predictors of Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials
|
Pinterpe, Giada
|
|
|
20 |
3 |
p. 405-418
|
artikel
|
Tijdschrift beschrijving